BiotechRecap185

Biotech Movers

Recent Articles

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

3 Biotechs to Buy and 1 to Sell Now

Biotechs are a sector where the whisper of FDA approval can send stocks soaring or falling. Here are 4 biotech stocks to watch for 2014, including 3 buys More 

3 Biotech Stocks Where Momentum is Alive and Well

If you are looking around the biotech space for the next knockout winner, take a look at these 3 contenders for the next big runup. More 

3 Perfect Biopharma Picks for Your Portfolio

If you want to play the volatile biopharma arena, choose carefully. Here are three hot stocks in the sector for different risk tolerances and time horizons. More 

3 Biopharma Runners With Fuel in the Tank

Biopharmaceutical stocks have been on a tear so far this year, but a few still have the pipeline power necessary to keep flying. More 

Bull’s Eye Report: Pharmacyclics (PCYC)

Biotech is a hot industry that's extremely volatile right now. Get on the right side of that volatility with Pharmacyclics (PCYC). More 

Bulls vs. Bears: Can Biogen Keep Booming?

Biogen has been soaring on news of its recent drug approval, but the question remains when it can keep it up. Here are the bullish and bearish arguments. More 

Biotech Movers: Acadia Jumps, Affymax Crashes

Last week, Acadia Pharmaceuticals rode the winds of good clinical results, while news of mass layoffs sent Affymax crashing again. More 

Biotech Movers: Spectrum, AEterna Among Big Losers

A stopped phase 3 trial grounded AEterna Zentaris and a downshift in guidance kneecapped Spectrum Pharmaceuticals last week. More 

Biotech Movers: Peregrine, PharmAthene Climb on Analyst Coverage

Last week in biotech news, Peregrine and PharmAthene both climbed on bullish analyst coverage. Also, find out why Sequenom shed double-digits in one day. More